Yonekura K, Kawakita T, Saito Y, Suzuki A, Nomoto K
Traditional Chinese Medicine Research Laboratories, Kanebo Co. Ltd., Osaka, Japan.
Immunopharmacol Immunotoxicol. 1992;14(1-2):165-90. doi: 10.3109/08923979209009218.
Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to, NIN), a traditional Chinese medicine, is a drug made of spray-dried powder of hot water extract obtained from twelve species of medical plants. An intraperitoneal (ip) injection with NIN 2 days before intravenous (iv) infection with Listeria monocytogenes (L. monocytogenes) accelerated elimination of viable bacteria in the spleen in the early stage of infection (from day 1) and protected mice from the lethal infection. It was suggested that the protective effect of NIN was mediated by the activation of nonimmune macrophages playing a principle role in resistance in the early stage of infection. Two days after ip injection with NIN just before infection, significantly increment in the number of monocytes in the peripheral blood was observed, though macrophage number in the spleen and their intracellular killing activity were unchanged. At 12 hours after infection with L. monocytogenes, a significantly enhanced increase of splenic macrophage number was observed in NIN-treated mice, compared to controls. After ip injection of NIN, interleukin-1 (IL-1), IL-6 and granulocyte macrophage-colony stimulating factor (GM-CSF) became detectable in the serum or peritoneal cavity. These results suggested that NIN stimulated macrophage-precursor cells in the bone marrow via the production of IL-1, IL-6, GM-CSF by macrophages, accelerated the supply of peripheral macrophages, and such macrophages accumulated into the site of infection in the very early stage of infection. Similar protective effects of NIN were observed by oral administration for 7 days till 1 day before iv infection with L. monocytogenes.
人参养荣汤(日语名称:人参养栄汤,NIN)是一种中药,由12种药用植物热水提取物的喷雾干燥粉末制成。在静脉注射感染单核细胞增生李斯特菌(L. monocytogenes)前两天腹腔注射NIN,可加速感染早期(第1天开始)脾脏中活菌的清除,并保护小鼠免受致命感染。有人认为,NIN的保护作用是通过激活非免疫巨噬细胞介导的,这些巨噬细胞在感染早期的抵抗力中起主要作用。在感染前腹腔注射NIN两天后,外周血单核细胞数量显著增加,尽管脾脏中的巨噬细胞数量及其细胞内杀伤活性没有变化。在感染单核细胞增生李斯特菌12小时后,与对照组相比,NIN处理的小鼠脾脏巨噬细胞数量显著增加。腹腔注射NIN后,血清或腹腔中可检测到白细胞介素-1(IL-1)、IL-6和粒细胞巨噬细胞集落刺激因子(GM-CSF)。这些结果表明,NIN通过巨噬细胞产生IL-1、IL-6、GM-CSF刺激骨髓中的巨噬细胞前体细胞,加速外周巨噬细胞的供应,并且这些巨噬细胞在感染的极早期就聚集到感染部位。在静脉注射感染单核细胞增生李斯特菌前7天口服NIN直至前1天,观察到NIN具有类似的保护作用。